Santiago Ponce Selected Research

Toll-Like Receptors (Toll-Like Receptor)

1/2020

Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Santiago Ponce Research Topics

Disease

19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 02/2015
16	Neoplasms (Cancer) 05/2024 - 01/2016
10	Disease Progression 01/2022 - 08/2015
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2017
4	Neutropenia 01/2023 - 08/2015
2	Malignant Mesothelioma 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Sepsis (Septicemia) 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 10/2020 - 03/2018
1	Bites and Stings (Sting) 02/2024
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Anemia 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2022
1	Atrial Fibrillation 01/2022
1	Mesothelioma 01/2022
1	Liver Failure 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Adenocarcinoma of Lung 12/2021
1	Sudden Death 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Hepatitis 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Pancytopenia 01/2021
1	Pulmonary Embolism 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Febrile Neutropenia 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Dehydration (Water Stress) 01/2021
1	Enterocolitis 01/2021
1	Necrosis 10/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2020
1	Adenocarcinoma 01/2020
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Pain (Aches) 08/2019
1	Paraneoplastic Polyneuropathy 08/2019
1	Neuralgia (Stump Neuralgia) 08/2019
1	Brain Neoplasms (Brain Tumor) 06/2019
1	Inflammation (Inflammations) 01/2018
1	Infections 01/2017
1	Hyponatremia 01/2016

Drug/Important Bio-Agent (IBA)

9	PlatinumIBA 01/2023 - 08/2015
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2016
4	Immune Checkpoint InhibitorsIBA 05/2024 - 03/2018
4	durvalumabIBA 11/2023 - 11/2019
4	Pemetrexed (MTA)FDA Link 01/2023 - 01/2018
4	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2017
3	NivolumabIBA 08/2023 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 08/2015
2	Cell-Free Nucleic AcidsIBA 02/2024 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2017
2	Circulating Tumor DNAIBA 01/2023 - 11/2022
2	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2016
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2017
2	PM 01183IBA 12/2020 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 01/2017
2	RamucirumabIBA 01/2018 - 01/2017
2	Gefitinib (Iressa)FDA Link 12/2017 - 08/2015
1	Abiraterone AcetateIBA 11/2023
1	enzalutamideIBA 11/2023
1	Androgen Receptors (Androgen Receptor)IBA 11/2023
1	anetumab ravtansineIBA 01/2022
1	olaparibIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	MesothelinIBA 01/2022
1	nintedanibIBA 12/2021
1	Docetaxel (Taxotere)FDA Link 12/2021
1	tremelimumabIBA 01/2021
1	Poly I-CIBA 10/2020
1	BO-112IBA 10/2020
1	pembrolizumabIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	secretin receptorIBA 01/2020
1	Trefoil FactorsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	SerpinsIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2018
1	ruxolitinibIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2017
1	lorvotuzumab mertansineIBA 01/2017
1	E-SelectinIBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Drug CombinationsIBA 07/2016
1	necitumumabIBA 02/2016
1	Tolvaptan FDA Link 01/2016

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 08/2023 - 08/2015
10	Therapeutics 05/2024 - 07/2016
2	Aftercare (After-Treatment) 01/2020 - 10/2016
1	Castration 11/2023
1	Radiotherapy 01/2022
1	Immunotherapy 01/2020
1	Intravenous Infusions 01/2020